INTERLEUKIN-1 MUTEINS USEFUL AS VACCINE ADJUVANTS
The present invention concerns compositions comprising an IL-1 mutein that is useful as an adjuvant for stimulating a controlled immune response when administered to a human or animal. For example, muteins of IL-1 beta can be used according to the invention. The mutein composition can include a vacc...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
21.02.2002
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention concerns compositions comprising an IL-1 mutein that is useful as an adjuvant for stimulating a controlled immune response when administered to a human or animal. For example, muteins of IL-1 beta can be used according to the invention. The mutein composition can include a vaccine antigen, such as whole inactivated or attenuated virus, recombinant or synthetic peptides, and other antigenic materials. The present invention also pertains to the use of an IL-1 mutein in a human or animal as an adjuvant to increase immune responses to an antigen or other material to which an immune response is desired.
La présente invention concerne des compositions comprenant une mutéine IL-1 qui est utile comme adjuvant pour stimuler une réponse immune contrôlée lors de son administration à l'homme ou à l'animal. Par exemple, des mutéines d'IL-1 beta peuvent être utilisées selon cette invention. La composition de mutéines peut comprendre un antigène vaccinal tel qu'un virus inactivé ou atténué entier, des peptides de recombinaison ou synthétiques et autres matériaux antigéniques. Cette invention concerne également l'utilisation d'une mutéine IL-1 humaine ou animale comme adjuvant pour accroître les réponses immunes dirigées vers un antigène ou autre matériau pour lequel une réponse immune est désirée. |
---|---|
AbstractList | The present invention concerns compositions comprising an IL-1 mutein that is useful as an adjuvant for stimulating a controlled immune response when administered to a human or animal. For example, muteins of IL-1 beta can be used according to the invention. The mutein composition can include a vaccine antigen, such as whole inactivated or attenuated virus, recombinant or synthetic peptides, and other antigenic materials. The present invention also pertains to the use of an IL-1 mutein in a human or animal as an adjuvant to increase immune responses to an antigen or other material to which an immune response is desired.
La présente invention concerne des compositions comprenant une mutéine IL-1 qui est utile comme adjuvant pour stimuler une réponse immune contrôlée lors de son administration à l'homme ou à l'animal. Par exemple, des mutéines d'IL-1 beta peuvent être utilisées selon cette invention. La composition de mutéines peut comprendre un antigène vaccinal tel qu'un virus inactivé ou atténué entier, des peptides de recombinaison ou synthétiques et autres matériaux antigéniques. Cette invention concerne également l'utilisation d'une mutéine IL-1 humaine ou animale comme adjuvant pour accroître les réponses immunes dirigées vers un antigène ou autre matériau pour lequel une réponse immune est désirée. |
Author | DONDERO, RICHARD, S STAATS, HERMAN, F |
Author_xml | – fullname: STAATS, HERMAN, F – fullname: DONDERO, RICHARD, S |
BookMark | eNrjYmDJy89L5WQw9PQLcQ3ycQ319vTTNVTwDQ1x9fQLVggNdnUL9VFwDFYIc3R29vRzVXB08QoNc_QLCeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHh_gaGxpYWBsaOxsZEKAEACFkoEg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | MUTEINES DE L'INTERLEUKINE 1 UTILES COMME ADJUVANTS DE VACCINS |
Edition | 7 |
ExternalDocumentID | WO0139803A3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO0139803A33 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:17:40 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO0139803A33 |
Notes | Application Number: WO2000US32813 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020221&DB=EPODOC&CC=WO&NR=0139803A3 |
ParticipantIDs | epo_espacenet_WO0139803A3 |
PublicationCentury | 2000 |
PublicationDate | 20020221 |
PublicationDateYYYYMMDD | 2002-02-21 |
PublicationDate_xml | – month: 02 year: 2002 text: 20020221 day: 21 |
PublicationDecade | 2000 |
PublicationYear | 2002 |
RelatedCompanies | DUKE UNIVERSITY CELLTECH CHIROSCIENCE LTD |
RelatedCompanies_xml | – name: CELLTECH CHIROSCIENCE LTD – name: DUKE UNIVERSITY |
Score | 2.5519967 |
Snippet | The present invention concerns compositions comprising an IL-1 mutein that is useful as an adjuvant for stimulating a controlled immune response when... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | INTERLEUKIN-1 MUTEINS USEFUL AS VACCINE ADJUVANTS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020221&DB=EPODOC&locale=&CC=WO&NR=0139803A3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGQMANBojxUg6ot4qVlK49VKhLU41pbSfWlt2mPhJplzGxIv4-brQNLnCLEsl5SI79OfFngPuyL_pF1a90apZSN6VD9byiJjpyZmFY0pBCNgH9MLKGqTmaPc1asNjmwiie0C9FjogaVaK-1-q-Xv0EsXz1t3L9UCyw6_05SFxf26JjhPKPhuYPXD6J_ZhpjCFu06JXt_F07B716B7sN150Q7PPs0GTlLL6bVGCEziYoLBlfQotsezAEdsWXuvAYbh578bmRvXWZ2Ao8toxTxFv6wYJ04Qj8CbplAfpmHhTknmMvUSceP4ozbwomZ4DCXjChjrOPd_tc_4W71ZJL6CN8F9cAnFsYUl0u3LEsaakRWE5tCztvCdtKhBTdqH7p5irf8au4VhVNmnSs40baNcfn-IWDWxd3Kmj-QZ-Sns_ |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3NT8IwFMBfEI14U9SInz2Y3RaZnfs4LGZ0WwC3QWRDbmQfbcIFicz47_vWAHrRW9Mm7WuT1_d-bd8rwH1hcjMvzVKleiFUXdhUzUqqoyOn55ohNMFFfaAfxUY_1Yezp1kDFttYGJkn9EsmR0SNKlDfK7lfr34OsTz5tnL9kC-w6v05SBxP2dIxovyjpng9xx-PvBFTGENuU-JXp_Z0rC516R7sm0iEkpSmvTooZfXbogTHcDDGzpbVCTT4sg0ttv14rQ2H0ea-G4sb1VufgiaT14Z-irytaiRKEx_Bm6QTP0hD4k7I1GVsEPvE9Ybp1I2TyRmQwE9YX8Wx57t5zt9GOynpOTQR__kFENvihkC3K0OpdUHz3LBpUVhZV1iUI1N2oPNnN5f_tN1Bq59E4TwcxC9XcCR_OalDtbVraFYfn_wGjW2V38pl-gZmyH4p |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INTERLEUKIN-1+MUTEINS+USEFUL+AS+VACCINE+ADJUVANTS&rft.inventor=STAATS%2C+HERMAN%2C+F&rft.inventor=DONDERO%2C+RICHARD%2C+S&rft.date=2002-02-21&rft.externalDBID=A3&rft.externalDocID=WO0139803A3 |